| abstract |
Omeprazole is the first listed proton pump inhibitor, and its clinical efficacy and safety have been confirmed for a long time and widely. There is no difference in the pump inhibitors, and other newly marketed proton pump inhibitors have price advantages, and are currently the most widely used proton pump inhibitors in clinical practice. The invention discloses a dissolution determination method of omeprazole chewable tablets. |